Ibezapolstat
ACX-362E-201
Phase 2 small_molecule completed
Quick answer
Ibezapolstat for Clostridium Difficile Infection is a Phase 2 program (small_molecule) at Acurx Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Acurx Pharmaceuticals
- Indication
- Clostridium Difficile Infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed